
French multinational Sanofi have begun stockpiling drugs in preparation for a no-deal Brexit. The company will join AstraZeneca and MSD …

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …

Sanofi announced yesterday that they have stopped production at their plant in the French Pyrenees following complaints that the factory …

The new July/August edition of Pharmafocus is now available to read online.

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …

Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …

A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …